Mainz Biomed N.V. (BST:4TO)
6.64
-0.10 (-1.48%)
Inactive · Last trade price
on Dec 5, 2024
Mainz Biomed Revenue
Mainz Biomed had revenue of $260.39K USD in the quarter ending June 30, 2024, with 4.60% growth. This brings the company's revenue in the last twelve months to $917.20K, up 16.23% year-over-year. In the year 2023, Mainz Biomed had annual revenue of $895.48K with 69.00% growth.
Revenue (ttm)
$917.20K
Revenue Growth
+16.23%
P/S Ratio
n/a
Revenue / Employee
$12.92K
Employees
71
Market Cap
10.99M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 895.48K | 365.60K | 69.00% |
Dec 31, 2022 | 529.88K | -47.47K | -8.22% |
Dec 31, 2021 | 577.35K | 83.78K | 16.98% |
Dec 31, 2020 | 493.57K | 212.17K | 75.40% |
Dec 31, 2019 | 281.39K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMainz Biomed News
- 5 days ago - EQS-News: Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval - Wallstreet:Online
- 5 days ago - Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval - GlobeNewsWire
- 6 days ago - Mainz Biomed (MYNZ) Advances Colorectal Cancer Test With New Study - GuruFocus
- 6 days ago - Mainz Biomed (MYNZ) Sees Revenue Surge Amid Strong Demand for ColoAlert - GuruFocus
- 18 days ago - Mainz Biomed Narrows Its Losses, Grows Revenue For Full Year 2024 - Benzinga
- 4 weeks ago - Mainz Biomed B.V. GAAP EPS of -$22.36 misses by $15.81, revenue of $0.89M misses by $0.36M - Seeking Alpha
- 4 weeks ago - EQS-News: Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update - Wallstreet:Online
- 5 weeks ago - EQS-News: Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study - Wallstreet:Online